Annual report [Section 13 and 15(d), not S-K Item 405]

Net Income (Loss) Per Common Share

v3.26.1
Net Income (Loss) Per Common Share
12 Months Ended
Mar. 31, 2026
Earnings Per Share [Abstract]  
Net Income (Loss) Per Common Share

17. Net Income (Loss) Per Common Share

The Company has common stock and non-voting common stock outstanding. As both classes carry identical economic rights, earnings per share is presented on a combined basis. Basic income (loss) per share is computed using the weighted average number of combined common and non-voting common shares outstanding during the period.

Diluted income (loss) per share excludes potentially dilutive instruments, including restricted stock units, pre-funded warrants, and shares issuable upon conversion of the Series A Convertible Preferred Stock, when their inclusion would be anti-dilutive. For periods in which the Company reports a net loss available to common stockholders, all potentially dilutive instruments are excluded from the diluted share count as their inclusion would reduce the loss per share.

The accretion of the Preferred Units to their maximum redemption value is reflected as a reduction in net income (or increase in net loss) available to common and non-voting common stockholders in the computation of basic and diluted earnings per share, consistent with the two-class method requirements under ASC 260. Refer to Note 13 – Temporary Equity for additional information regarding the accretion of the Preferred Units and the issuance of the Series A Convertible Preferred Stock.

The following table presents the computation of basic and diluted net income (loss) per share for the fiscal years presented (in thousands, except per share amounts):

Year Ended March 31,

  ​ ​ ​

2026

  ​ ​ ​

2025

Numerator:

Consolidated net income (loss)

$

2,825

$

(7,190)

Less: Accretion to redemption value of Preferred Units

 

69,606

 

Net loss available to holders of common stock and non-voting common stock

$

(66,781)

$

(7,190)

Denominator:

Weighted average shares outstanding - common and non-voting common stock

 

20,833

 

19,056

Pre-funded warrants and other equivalents (1)

Weighted average shares outstanding - diluted

20,833

19,056

Net income (loss) per share - basic

$

(3.21)

$

(0.38)

Net income (loss) per share - diluted

$

(3.21)

$

(0.38)

 

(1) For fiscal years ended March 31, 2026 and 2025, all potentially dilutive instruments were excluded from the diluted share count as their inclusion would be anti-dilutive given the net loss available to common stockholders in each period.

 

 

The following table summarizes the potentially dilutive securities excluded from the diluted share calculation for each period presented:

Year Ended March 31,

  ​ ​ ​

2026

  ​ ​ ​

2025

Restricted stock units

848,626

726,823

Performance restricted stock units

103,981

53,533

Pre-funded warrants - November 2025 PIPE

3,520,000

Pre-funded warrants - March 2026 PIPE

300,000

Series A Convertible Preferred Stock (as-converted basis)

16,000,000

Total potentially dilutive securities excluded

20,772,607

780,356